134 related articles for article (PubMed ID: 9202817)
21. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
24. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.
Wiström J; Ahlm C; Lundberg S; Settergren B; Tärnvik A
Vaccine; 1999 Apr; 17(17):2162-5. PubMed ID: 10367949
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
27. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
Das K; Gupta RK; Kumar V; Kar P
World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
30. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
Mahallawi W
Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
[TBL] [Abstract][Full Text] [Related]
31. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
33. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.
Katkov WN; Watkins E; DeMelia HC; Dienstag JL
J Viral Hepat; 1994; 1(1):79-83. PubMed ID: 8790563
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.
del Canho R; Grosheide PM; Voogd M; Huisman WM; Heijtink RA; Schalm SW
J Med Virol; 1993 Sep; 41(1):30-4. PubMed ID: 8228934
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
Schiff GM; Sherwood JR; Zeldis JB; Krause DS
J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
[TBL] [Abstract][Full Text] [Related]
37. [Immunogenicity of the Heberbiovac-HB vaccine in the physically and mentally handicapped].
Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González JR
Rev Cubana Med Trop; 1997; 49(1):59-63. PubMed ID: 9685963
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
[TBL] [Abstract][Full Text] [Related]
39. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses.
Lai CL; Wong BC; Yeoh EK; Lim WL; Chang WK; Lin HJ
Hepatology; 1993 Oct; 18(4):763-7. PubMed ID: 8406348
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
Coates T; Wilson R; Patrick G; André F; Watson V
Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]